Name | TMI 1 |
---|---|
Synonyms |
3-Thiomorpholinecarboxamide, 4-[[4-(2-butyn-1-yloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-, (3S)-
TMI 1 4-[[4-(2-Butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide TMI-1 (3S)-4-{[4-(2-Butyn-1-yloxy)phenyl]sulfonyl}-N-hydroxy-2,2-dimethyl-3-thiomorpholinecarboxamide (3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE WAY-171318 |
Description | TMI-1 is a potent inhibitor of disintegrin metalloenzyme 17 (ADAM17) and other MMPs. TMI-1 inhibits LPS-induced TNF-α secretion in human primary monocytes, and human whole blood[1]. TMI-1 selectively induces caspase-dependent apoptosis in triple negative (TN) and ERBB2-overexpressing breast tumor cell lines[2]. |
---|---|
Related Catalog | |
Target |
ADAM17:8.4 nM (IC50) |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Molecular Formula | C17H22N2O5S2 |
Molecular Weight | 398.497 |
Exact Mass | 398.097015 |
LogP | 2.56 |
Index of Refraction | 1.590 |